Related references
Note: Only part of the references are listed.Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway
Syue-Ting Chen et al.
ONCOGENE (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Reactive oxygen species and cancer paradox: To promote or to suppress?
Sehamuddin Galadari et al.
FREE RADICAL BIOLOGY AND MEDICINE (2017)
MUC13 overexpression in renal cell carcinoma plays a central role in tumor progression and drug resistance
Yonghua Sheng et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria
Allimuthu T. Dharmaraja
JOURNAL OF MEDICINAL CHEMISTRY (2017)
MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin beta 1 pathway
Chi-Hau Chen et al.
GYNECOLOGIC ONCOLOGY (2016)
Reactive Oxygen Species Regulate T Cell Immune Response in the Tumor Microenvironment
Xinfeng Chen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Advances in the Management of Recurrent Endometrial Cancer
Leslie S. Bradford et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2015)
Mucins: A biologically relevant glycan barrier in mucosal protection
Anthony P. Corfield
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma
Salvia Jain et al.
BLOOD (2015)
Cytokine Stimulation of MUC4 Expression in Human Female Reproductive Tissue Carcinoma Cell Lines and Endometrial Cancer
Patricia J. Chapela et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
Mucins in Lung Cancer Diagnostic, Prognostic, and Therapeutic Implications
Imayavaramban Lakshmanan et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma
Yoshiaki Kamikawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
A signaling pathway consisting of miR-551b, catalase and MUC1 contributes to acquired apoptosis resistance and chemoresistance
Xiuling Xu et al.
CARCINOGENESIS (2014)
MUC20 overexpression predicts poor prognosis and enhances EGF-induced malignant phenotypes via activation of the EGFR-STAT3 pathway in endometrial cancer
Chi-Hau Chen et al.
GYNECOLOGIC ONCOLOGY (2013)
Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer
Xiuying Xiao et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells
S. Bafna et al.
ONCOGENE (2010)
Regulation of Autophagy by Reactive Oxygen Species (ROS): Implications for Cancer Progression and Treatment
Meghan B. Azad et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Mucins in cancer: function, prognosis and therapy
Donald W. Kufe
NATURE REVIEWS CANCER (2009)
Clinical potential of mucins in diagnosis, prognosis, and therapy of ovarian cancer
Ajay P. Singh et al.
LANCET ONCOLOGY (2008)
The mucin expression profile of endometrial carcinoma and correlation with clinical-pathologic parameters
Carl Morrison et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
Cell surface-associated mucins in signal transduction
Pankaj K. Singh et al.
TRENDS IN CELL BIOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mucins in cancer: Protection and control of the cell surface
MA Hollingsworth et al.
NATURE REVIEWS CANCER (2004)
Share Paper
